Autism Care Therapy

Approximately 1 in 31 children in the United States has been identified with Autism Spectrum Disorder, and that statistic represents not just a public health reality but an acute, daily crisis for hundreds of thousands of families who cannot access the specialized care their children need. Waitlists stretch for months, qualified providers are scarce, and the gap between diagnosis and consistent treatment widens each year as prevalence rates climb. Autism Care Therapy — headquartered in Lombard, Illinois — was built to close that gap. The company was founded by a Board-Certified Behavior Analyst who has personal experience raising a child with autism, which means the clinical and operational decisions at ACT originate from a place of lived urgency rather than abstract business strategy. Autism Care Therapy began franchising in 2021, making it a relatively young entrant in a sector that is rapidly institutionalizing, and it currently operates 7 total locations in the United States, composed of 4 company-owned units and 3 franchised locations. The franchise model is structured to combine the responsiveness and warmth of a locally owned clinic with the clinical rigor, training infrastructure, and operational consistency of a scaled healthcare enterprise. Wassim Al Mala, PhD, serves as CFO, General, and HR Manager, bringing a doctorate in Business Administration from France and more than 10 years of management experience to a company that has used the past three years to strengthen its operational core, expand its geographic footprint, and build the staffing infrastructure necessary to support franchise growth. For prospective franchise investors evaluating the Autism Care Therapy franchise opportunity, the essential question is whether this brand's clinical foundation, Item 19 financial disclosures, and early-stage positioning represent a compelling entry point into one of the most durable growth markets in American healthcare. This analysis is produced independently by PeerSense and contains no promotional content from Autism Care Therapy or its representatives.

The autism spectrum disorder treatment market is not a niche — it is one of the fastest-growing segments in all of American healthcare, and the macro forces driving that growth show no signs of reversing. The U.S. autism treatment market was estimated at $4.4 billion in 2024, and Marketdata projects 3.8% annual revenue growth through 2028, with the U.S. market projected to reach $5.11 billion by 2026. Globally, the ASD treatment market was valued at $8.55 billion in 2025 and is forecast to grow to $18.68 billion by 2034, representing a compound annual growth rate of 9.23% over the forecast period. Applied Behavior Analysis remains the dominant evidence-based intervention within this market, and Mordor Intelligence estimates the ABA-specific market at $7.97 billion in 2025, projecting growth to $9.96 billion by 2030 at a CAGR of approximately 4.56%. Autism diagnoses have increased by 175% over the last decade alone, and with 1 in 31 U.S. children now identified on the spectrum, the addressable patient population continues to expand. Several structural forces are accelerating franchise investment in this category: changes to federal and state insurance laws now compel carriers to reimburse ABA and related autism therapies, Medicaid spending on autism treatment has surged, and data from California shows that over 50% of services were delivered in clinic-based settings in 2025, reinforcing the viability of the brick-and-mortar franchise model. Multidisciplinary care models — combining ABA with speech, occupational, and physical therapy under one roof — have been growing at a 30% compound annual growth rate since 2020, and ABA providers that have integrated allied therapies are capturing a disproportionate share of family enrollment. The therapist shortage remains the most significant operational headwind, with employee turnover persisting despite a 25% year-over-year increase in providers nationwide, which creates both a staffing challenge and a competitive barrier that favors established franchise systems with structured training pipelines. AI-enabled operational tools are now adopted by approximately 75% of organizations in the space, digitizing workflow and accelerating therapy accessibility in ways that franchise infrastructure is uniquely positioned to deploy at scale.

The Autism Care Therapy franchise investment begins with a franchise fee of $65,000, which positions it at the upper-middle tier of the autism therapy franchise category — for context, Success On The Spectrum charges $39,500, AutismCOE charges $35,000, and Essential Speech and ABA Therapy charges $49,500. The total initial investment range for an Autism Care Therapy franchise spans $338,300 to $734,200, a spread that reflects meaningful variability in lease terms, geographic construction costs, facility build-out complexity, and the scale of the clinical space required to serve the target caseload. That range is broadly comparable to Essential Speech and ABA Therapy, which estimates $267,500 to $698,750, and falls above Success On The Spectrum's revised estimate of $313,500 to $851,300 at the high end. The ongoing royalty rate for the Autism Care Therapy franchise is 7%, which is higher than the 5% charged by both AutismCOE and Essential Speech and ABA Therapy, and the advertising fee adds an additional 3% of gross revenue, bringing the combined ongoing fee burden to 10% of gross sales. Investors should model this fee structure against Item 19 revenue data carefully: at the disclosed average revenue of $2.62 million, the combined royalty and advertising obligation represents approximately $262,000 annually before accounting for rent, payroll, insurance, and other operating costs. The franchise agreement runs for a 10-year term, providing meaningful operational runway for a franchisee to build clinical reputation, grow caseload, and achieve a mature-stage return on invested capital. The total cost of ownership analysis should also incorporate the revenue cycle reality specific to this industry: Essential Speech and ABA Therapy's FDD notes it takes 7 to 10 weeks to intake a client from initial contact through insurance authorization, and payment on rendered services can take an additional 30 to 45 days, meaning franchisees must capitalize adequately for the pre-revenue ramp period. Investors with backgrounds in healthcare administration, behavioral health, or education tend to underestimate build-out timelines and overestimate early-stage revenue velocity, making conservative cash reserve planning essential during the first 12 months of operations.

The daily operating model of an Autism Care Therapy franchise center revolves around the delivery of evidence-based Applied Behavior Analysis therapy to children with Autism Spectrum Disorder, with services provided by a clinical team led by Board-Certified Behavior Analysts and staffed by Registered Behavior Technicians who implement individualized treatment plans under BCBA supervision. This is a labor-intensive, high-supervision model, and the staffing structure is the largest single cost center in the business — industry benchmarks for ABA therapy practices typically show payroll consuming 55% to 70% of gross revenue, which investors must account for when modeling net operating income. Success On The Spectrum, one of the sector's most established franchise systems, established that caseload limits should be set to ensure clinical oversight and allow for individual program reviews, a philosophy that reflects best practice in the ABA space and directly influences the staffing ratios that drive profitability. The Autism Care Therapy franchise model was built by a BCBA founder whose primary goal from inception was to build a high-quality program that prioritizes the child, and that clinical-first orientation shapes how the franchise deploys training and monitors outcomes across units. Franchisees receive training throughout the entire startup process, covering clinical program design, operational systems, billing and insurance credentialing, and staff recruitment — areas where first-time healthcare business owners typically face the steepest learning curves. The operational reality of insurance-based revenue is significant: billing and credentialing workflows, authorization management, and claims follow-up require dedicated administrative infrastructure, and franchisors that provide billing support — as AutismCOE and Essential Speech and ABA Therapy both advertise — meaningfully reduce the operational burden on the franchisee. Territory structure provides franchisees with a defined geographic operating area, and the company's current footprint of 7 total locations across the United States suggests that the brand is in an active territory development phase, with substantial white space available for new franchisees in most U.S. markets. The owner-operator model is most consistent with how early-stage healthcare franchises scale, and investors who intend to be present in the business — engaging with clinical staff, managing insurer relationships, and participating in community outreach — are positioned to outperform absentee ownership structures in this category.

Autism Care Therapy discloses Item 19 financial performance data in its Franchise Disclosure Document, which is a meaningful differentiator from franchises in this category that withhold earnings information entirely. The disclosed average revenue across reporting units is $2.62 million, with a median revenue of $2.58 million — a tight spread between the average and median that suggests relatively consistent performance across the reporting unit base rather than a situation where a few outlier performers inflate the average. For comparison, Essential Speech and ABA Therapy reports an Average Unit Volume of $1,113,891 for franchised units billing all 52 weeks in 2024, while its company-owned locations report an AUV of $1,283,973 — figures that are substantially below Autism Care Therapy's disclosed average. ACT's Item 19 also discloses estimated earnings in the range of $787,312 to $1,049,749 on yearly gross sales of $5,248,744, representing implied operating margins of approximately 15% to 20% — a range consistent with well-run ABA therapy practices that have achieved clinical maturity and efficient billing operations. The franchise payback period is disclosed at 1.1 to 3.1 years, which is an unusually short payback window for a healthcare franchise requiring investment in the $338,300 to $734,200 range, and investors should scrutinize the assumptions underlying this projection carefully in the context of their specific market, staffing costs, and lease terms. The 7% royalty rate, while higher than some category peers, is more palatable at a $2.62 million revenue scale than at the $1.1 million AUV reported by some competitors — the dollar-weighted royalty burden at ACT's average revenue is approximately $183,400 annually, and the remaining gross profit pool above that figure and above operating costs determines the franchisee's actual return on invested capital. Revenue alone does not indicate profitability, as operating costs in clinic-based ABA services vary significantly by geography, staff tenure, caseload density, and insurance payer mix, and investors should request audited or reviewed financial statements from existing franchisees as part of formal validation.

Autism Care Therapy began franchising in 2021 and currently operates 7 total U.S. locations, with 4 company-owned units representing a majority of the system — a unit composition that indicates the franchisor is still actively proving the model in corporate locations before aggressively scaling the franchise network. This is actually a positive signal for prospective franchisees: corporate-owned locations that operate at $2.62 million in average revenue generate real-world operational data that informs training, support, and Item 19 disclosures, and they serve as a development laboratory for refining clinical protocols and administrative workflows. The broader autism therapy franchise sector is scaling rapidly — ABA Centers, founded in 2020, achieved revenue growth of 5,794% between 2021 and 2023 and plans to open approximately 40 new centers in 2025, while Behavior Frontiers announced four new Minneapolis-area centers in March 2026, bringing its Minnesota total to eight. Success On The Spectrum has scaled to over 80 locations, with 37 U.S. centers open as of June 2024 including 35 franchised locations. ACES operates more than 80 locations across 9 states. Against this competitive backdrop, Autism Care Therapy's 7-unit footprint represents early-stage positioning, and the Autism Care Therapy franchise opportunity carries the risk profile and upside potential associated with a brand that has not yet achieved system-wide scale. The competitive moat for ACT at this stage rests on its clinical pedigree — a BCBA-founded organization with a family-centered, child-first mission — and on its demonstrated unit-level economics, which compare favorably to more established franchise brands. The integration of AI-enabled operational tools, which approximately 75% of ABA organizations have adopted in the past year, represents both an operational necessity and a potential differentiator for franchisors that embed these tools into their core systems and training programs. The 2025 autism and IDD market reported a nearly 20% year-over-year increase in service hours, a demand signal that directly benefits capacity-expanding franchise systems.

The ideal Autism Care Therapy franchise candidate is not required to hold a clinical license or prior ABA experience — consistent with how leading autism therapy franchise systems are designed, where the franchisor provides clinical infrastructure and the franchisee provides operational leadership, community engagement, and business management capability. Candidates with backgrounds in healthcare administration, education management, social services, or multi-unit retail operations are well-suited to the staffing-intensive, insurance-reimbursement-driven business model that defines the autism therapy franchise category. The 10-year franchise agreement term provides sufficient runway to build clinical reputation, negotiate improved payer contracts, and develop a multi-therapist center that reaches the revenue levels reflected in ACT's Item 19 disclosures. Multi-unit development is a common growth path in the ABA therapy franchise sector, as demonstrated by Success On The Spectrum's Austin expansion strategy, which envisions opening in multiple neighborhoods and suburbs, partnering with local universities for practicum placement, and building a collaborative local franchisee network. For Autism Care Therapy, the current 7-unit system with substantial U.S. white space means that early franchisees are positioned to secure priority territory in markets where the ACT brand has not yet established a clinical presence — a first-mover advantage that can be meaningful in a referral-driven, community-embedded service business where pediatricians, school districts, and early intervention networks direct families to providers they trust. Timeline from signing to opening in clinic-based ABA therapy typically ranges from 9 to 18 months, driven by lease negotiation, licensure, BCBA hiring, and insurance credentialing timelines, and investors should plan cash reserves accordingly. The disclosed payback period of 1.1 to 3.1 years creates a wide range of outcomes depending on market execution, and the difference between the low and high end of that range will largely be determined by how quickly the franchisee builds a full caseload and retains clinical staff in a competitive labor market.

Any franchise investor conducting serious due diligence on the Autism Care Therapy franchise opportunity must evaluate it within the full context of a sector where average unit volumes, royalty structures, staffing models, and insurance reimbursement dynamics vary substantially across competing brands — and where the difference between a well-supported franchise system and an under-resourced one can determine whether a $338,300 to $734,200 investment generates a 1.1-year payback or an extended capital recovery period. The disclosed average revenue of $2.62 million and median of $2.58 million are among the strongest unit-level performance figures in the autism therapy franchise category, the franchise's BCBA-founded clinical roots and family-centered philosophy align with the values of the families it serves, and the global ASD treatment market's trajectory toward $18.68 billion by 2034 provides a durable demand floor that few healthcare franchise categories can match. At the same time, the 7% royalty rate, 3% advertising fee, and relatively small 7-unit system require careful scrutiny of how the franchisor's support infrastructure scales alongside network growth — questions that Item 19 data alone cannot fully answer. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark the Autism Care Therapy franchise against every competing brand in the autism therapy and ABA services category. Whether you are evaluating ACT alongside Essential Speech and ABA Therapy, weighing the clinical positioning of a BCBA-founded franchise against a larger-scale system, or simply trying to determine whether the disclosed payback period assumptions hold up against real-world unit economics, the independent data infrastructure on PeerSense is the most complete resource available for this analysis. Explore the complete Autism Care Therapy franchise profile on PeerSense to access the full suite of independent franchise intelligence data.